• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Database: Ovid MEDLINE(R) <1996 to January Week 4 2009>
Search Strategy:
1Advicor.mp. (9)
2Vytorin.mp. (16)
3Simcor.mp. (3)
4(lovastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (76)
5(simvastatin and ezetimibe).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (234)
6(simvastatin and niacin).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (90)
7lovastatin.mp. or exp Lovastatin/(5022)
8simvastatin.mp. or exp Simvastatin/(3948)
9niacin.mp. or exp Niacin/(1922)
10niacin extended release.mp. (19)
11Niacin ER.mp. (21)
12(niacin adj3 extend$ release).mp. [mp=title, original title, abstract, name of substance word, subject heading word] (94)
13ezetimibe.mp. (784)
14Zetia.mp. (26)
151 or 2 or 3 or 4 or 5 or 6 (355)
167 or 8 (5572)
179 or 10 or 11 or 12 or 13 or 14 (2624)
1816 and 17 (361)
1915 or 18 (363)
20from 19 keep 1–363 (363)

From: Appendix B, Search strategy

Cover of Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin
Drug Class Review: HMG-CoA Reductase Inhibitors (Statins) and Fixed-dose Combination Products Containing a Statin: Final Report Update 5 [Internet].
Smith MEB, Lee NJ, Haney E, et al.
Portland (OR): Oregon Health & Science University; 2009 Nov.
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.